{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T05:21:28Z","timestamp":1648704088994},"reference-count":17,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Problems in Pediatric and Adolescent Health Care"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.cppeds.2012.02.001","type":"journal-article","created":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T22:29:51Z","timestamp":1344551391000},"page":"193-197","source":"Crossref","is-referenced-by-count":0,"title":["Skin Signs of Severe Systemic Medication Reactions"],"prefix":"10.1016","volume":"42","author":[{"given":"James R.","family":"Treat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cppeds.2012.02.001_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.iac.2009.04.007","article-title":"The variable clinical picture of drug-induced hypersensitivity syndrome\/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug","volume":"29","author":"Kano","year":"2009","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.cppeds.2012.02.001_bib2","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1365-2133.2007.07807.x","article-title":"The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations","volume":"156","author":"Shiohara","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cppeds.2012.02.001_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2332\/allergolint.55.1","article-title":"Drug-induced hypersensitivity syndrome (DIHS): A reaction induced by a complex interplay among herpes viruses and antiviral and antidrug immune responses","volume":"55","author":"Shiohara","year":"2006","journal-title":"Allergol Int"},{"key":"10.1016\/j.cppeds.2012.02.001_bib4","first-page":"357","article-title":"The drug hypersensitivity syndrome: What is the pathogenesis?","volume":"137","author":"Sullivan","year":"2001","journal-title":"Arch of Dermatol"},{"key":"10.1016\/j.cppeds.2012.02.001_bib5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens\u2013Johnson Syndrome and toxic epidermal necrolysis: Comparison with case-control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cppeds.2012.02.001_bib6","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.clinthera.2008.05.014","article-title":"Acute generalized exanthematous pustulosis induced by hydroxychloroquine: Three cases and a review of the literature","volume":"30","author":"Paradisi","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.cppeds.2012.02.001_bib7","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/archderm.1991.01680080069004","article-title":"Acute generalized ex-anthematous pustulosis: Analysis of 63 cases","volume":"127","author":"Roujeau","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cppeds.2012.02.001_bib8","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1365-2133.2007.08156.x","article-title":"Risk factors for acute generalized exhanthematous pustulosis (AGEP)\u2014results of a multinational case-control study (EuroSCAR)","volume":"157","author":"Sidoroff","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cppeds.2012.02.001_bib9","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1001\/archderm.142.8.1080","article-title":"Acute generalized exanthematous pustulosis induced by clindamycin","volume":"142","author":"Kapoor","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cppeds.2012.02.001_bib10","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/j.1365-2133.2005.06568.x","article-title":"Acute localized exanthematous putulosis secondary to levofloxacin","volume":"152","author":"Corral de la Calle","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cppeds.2012.02.001_bib11","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(02)07873-X","article-title":"Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir","volume":"359","author":"Mallal","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cppeds.2012.02.001_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0923-1811(99)00083-3","article-title":"Virus-induced immune dysregulation as a triggering factor for the development of drug rashes and autoimmune diseases: With emphasis on EB virus, human herpes virus 6 and hepatitis C virus","volume":"22","author":"Mizukawa","year":"2000","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.cppeds.2012.02.001_bib13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cppeds.2012.02.001_bib14","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.cppeds.2012.02.001_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tox.2004.12.022","article-title":"Clinical heterogeneity of drug hypersensitivity","volume":"209","author":"Roujeau","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.cppeds.2012.02.001_bib16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2133.2011.10397.x","article-title":"Drug-induced subacute cutaneous lupus erythematosus: Evidence for differences from its idiopathic counterpart","volume":"165","author":"Marzano","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cppeds.2012.02.001_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.smj.0000197121.12352.19","article-title":"Hydralazine-induced lupus: Maintaining vigilance with increased use in patients with heart failure","volume":"99","author":"Finks","year":"2006","journal-title":"South Med J"}],"container-title":["Current Problems in Pediatric and Adolescent Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538544212000600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538544212000600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T15:51:10Z","timestamp":1542815470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538544212000600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1538544212000600"],"URL":"https:\/\/doi.org\/10.1016\/j.cppeds.2012.02.001","relation":{},"ISSN":["1538-5442"],"issn-type":[{"value":"1538-5442","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}